The mechanism of action may be related to the inhibition of IRF4, Notch1, and p-AKT signaling pathways and the reduction of the collagen activity in renal tissue, thereby slowing down the progression of the DN. This evidence concerns the gene NOTCH1 and liver dysplastic nodule.